Bayer poaches Otsuka's chief medical officer Koenen to head up its clinical operations

As Bayer looks to ramp up its R&D work in the gene therapy space amid a host of biotech tie-ups, the German pharma is tapping Christoph Koenen as its new global head of clinical development and operations in its R&D unit.

Related Keywords

Germany ,German ,Rd Christian Rommel ,Christoph Koenen ,Glaxosmithkline ,Bristol Myers Squibb ,Novo Nordisk ,New Year ,Big Pharmas ,Bristol Myers ,Vividion Therapeutics ,Bayer ,Tsuka ,Cell Amp Gene Therapy ,Ncology ,Chutes And Ladders ,Hiring ,Biotech ,